Alternatives to Adicet Bio

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Developing engineered biologics to harness the immune system for disease treatment.

Biotechnology company developing novel immunotherapies for cancer.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

Develops novel therapeutic antibodies for oncology and autoimmune diseases.

A global oncology company developing and commercializing innovative cancer treatments.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotech company developing next-generation gene writing tools for advanced therapies.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Biopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.

Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

Clinical-stage company developing novel oncology therapies to overcome tumor immune evasion and drug resistance.

Mabylon is a biotechnology company focused on developing innovative antibody-based therapies for infectious diseases and cancer.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Developing novel diagnostics to predict patient response to immunotherapy.

Immunotherapy company targeting oncology and autoimmune diseases.

Leveraging the adaptive immune system to diagnose and treat disease.

Clinical-stage immunotherapy company developing novel treatments for cancer.

Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Biotechnology company developing cell and gene therapies for serious diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Developing a novel KIR-based CAR T-cell therapy to overcome T-cell exhaustion and target solid tumors.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Biotech company developing novel therapeutics for regenerative medicine and oncology.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Developing novel therapeutics for cancer by targeting the tumor microenvironment.

Pillar Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel cancer therapies.